scispace - formally typeset
W

Won Kim

Researcher at Seoul Metropolitan Government

Publications -  282
Citations -  7345

Won Kim is an academic researcher from Seoul Metropolitan Government. The author has contributed to research in topics: Nonalcoholic fatty liver disease & Fatty liver. The author has an hindex of 35, co-authored 270 publications receiving 5135 citations. Previous affiliations of Won Kim include Seoul National University Hospital & New Generation University College.

Papers
More filters
Journal ArticleDOI

Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver disease

TL;DR: HSI is a simple, efficient screening tool for NAFLD that may be utilized for selecting individuals for liver ultrasonography and for determining the need for lifestyle modifications.
Journal ArticleDOI

Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis

TL;DR: Low muscle mass was found to be associated with histological severity in non-alcoholic fatty liver disease, and sarcopenia was significantly associated with non- alcoholic steatohepatitis and significant fibrosis, independent of obesity, inflammation, and insulin resistance.
Journal ArticleDOI

Nonalcoholic fatty liver disease is associated with coronary artery calcification

TL;DR: Patients with NAFLD are at increased risk for coronary atherosclerosis independent of classical coronary risk factors, including visceral adiposity, according to this data, which suggest thatNAFLD might be an independent risk factor for coronary artery disease.
Journal ArticleDOI

Non-alcoholic fatty liver disease across the spectrum of hypothyroidism

TL;DR: Subclinical hypothyroidism, even in the range of upper normal TSH levels, was found to be related to NAFLD in a dose-dependent manner, confirming a relevant clinical relationship between these two diseases.
Journal ArticleDOI

Distinct signatures of gut microbiome and metabolites associated with significant fibrosis in non-obese NAFLD.

TL;DR: Evidence is provided for the role of the microbiome in the liver fibrosis pathogenesis, especially in non-obese subjects, and significant alterations in microbiome diversity are observed according to fibrosis severity in non -obese, but not obese, subjects.